Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,605 total articles
Beta Bionics, Inc., a medical device company specializing in advanced diabetes management technology, announced it will release its third quarter 2026 financial results on October 27, 2026, followed by a management conference call and webcast to discuss performance.
The Metals Company has appointed Liam Mallon, ex-President of ExxonMobil Upstream, to its Board of Directors. Mallon's extensive experience in offshore energy projects and capital deployment will support TMC as it advances toward launching the world's first commercial-scale deep seabed mineral operations under U.S. regulatory frameworks. His leader…
Microchip Technology expands its Single Pair Ethernet portfolio with the launch of LAN8679 and LAN8680 10BASE-T1S PMD transceivers and the LAN8660X/1X/2X integrated endpoint family. These devices enable flexible, space-efficient, and reliable Ethernet connectivity for next-generation zonal architectures across automotive, industrial, robotics, aero…
Commerce (NASDAQ: CMRC) announced new AI-driven product data enrichment capabilities for BigCommerce and Feedonomics users, enabling merchants to transform their product catalogs into AI-ready, richly detailed inventories. These tools support improved product discoverability, streamlined catalog management, enhanced shopper engagement, and foster a…
One and One Green Technologies, Inc. announced financial results for the first half of 2026, reporting an 18.7% increase in revenue to $33.4 million and a 17.4% rise in net income to $4.5 million. Growth was fueled by a 39% increase in copper alloy ingot revenue due to stronger demand in Asia-Pacific and capacity reallocation, despite a temporary s…
Dianthus Therapeutics announced scheduled oral and poster presentations at the 2026 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting, showcasing encouraging Phase 2 and Phase 3 data for claseprubart, their investigational monoclonal antibody targeting autoimmune diseases such as generalized myasthenia grav…
Nasus Pharma has enrolled and dosed its first patient in the Phase 1 pharmacokinetic study of NS003, an intranasal powder formulation of ondansetron aimed at treating chemotherapy-induced and post-operative nausea and vomiting. Preclinical data showed NS003's pharmacokinetic profile comparable to IV ondansetron with a favorable safety profile. The …
SaverOne has been awarded a new U.S. patent for its advanced sensor fusion-based calibration and maintenance technology for its Phone Location Unit (PLU). This innovation allows the system to self-calibrate and maintain full operational accuracy over the vehicle's lifecycle, supporting efficient remote servicing at fleet scale. The patent strengthe…
Tokyo Lifestyle Co., Ltd. announced two key equity transactions approved by its board aimed at strengthening the company's capital structure. The Representative Director made a direct cash investment of approximately US$0.38 million, while an affiliated entity converted JPY510 million (approx. US$3.32 million) of outstanding shareholder-related deb…
Keros Therapeutics announced it will receive a $20 million development milestone payment from Takeda following the dosing of the first patient in the Phase 3 ELRiSE MF clinical trial of elritercept, a novel therapeutic targeting cytopenias in myelofibrosis patients. This milestone reflects progress under their 2025 global licensing agreement with T…
Phathom Pharmaceuticals announced the initiation of a registrational Phase 3 study (pHalcon-NERD-302) to evaluate VOQUEZNA (vonoprazan) as an as-needed treatment for Non-Erosive GERD (NERD). Building on positive Phase 2 data, this study aims to assess the efficacy and safety of VOQUEZNA in providing rapid and sustained relief of heartburn episodes.…
NewAmsterdam Pharma has dosed the first participant in its Phase 2b SPINOZA clinical trial evaluating obicetrapib, a novel oral CETP inhibitor, in adults with biomarker evidence of preclinical Alzheimer's disease. The trial involves approximately 400 patients with specific ApoE genotypes and aims to assess changes in Alzheimer's disease biomarkers …
Outdoor Holding Company, owner of GunBroker.com, the largest online firearms marketplace, will release its second quarter fiscal 2027 financial results on November 16, 2026, followed by a management conference call to discuss corporate developments and financial performance.
Provident Bank's 2026 Higher Education Survey shows nearly 70% of Americans are rethinking the financial value of traditional higher education amid rising costs, with increasing consideration for trade and technical schools as viable alternatives. The survey highlights gaps in education savings and a significant opportunity for banks to provide bet…
WW International, Inc. announces a strategic collaboration with Google Health Enterprise to enhance its weight management program through integration with Google's Fitbit Air wearable and AI-powered insights. The partnership aims to increase engagement and improve outcomes by offering personalized tracking of activity, sleep, and health signals to …
Maris-Tech Ltd. announced the completion of Diamond Ultra V2, a next-generation high-performance video and AI platform designed for demanding defense applications including situational awareness, terrain dominance, and counter-UAS. The platform integrates proprietary hardware and firmware and supports advanced imaging technologies, enabling a compr…
Apollo Global Management, a leading global alternative asset manager with $1.05 trillion in assets under management as of June 30, 2026, will announce its third quarter 2026 financial results on November 3, 2026, before the NYSE market opens. The company will host a webcast at 8:30 am ET to discuss the results and provide insights into its business…
ABM Industries, a major facility services provider, emphasizes its role in maintaining and preparing State Farm Stadium for the Arizona Cardinals NFL games and other major events. The partnership underlines ABM's capability in sports and entertainment venue management, boosting its presence in the Phoenix market and nationally.
European Wax Center, a leading US franchisor and operator of waxing services, announced renowned esthetician Joanna Czech as its first-ever brand ambassador and Chief Smooth Officer. Czech's appointment aligns with EWC's recent brand transformation emphasizing expertise in skincare as integral to waxing. The company is expanding its footprint with …
Diginex Limited (NASDAQ: DGNX) announced the launch of an enhanced end-to-end supply chain due diligence platform designed to provide companies with comprehensive visibility across multiple supplier tiers. This platform aims to help firms identify and mitigate risks, lower operating costs, reduce litigation exposures, and comply with evolving regul…
Leonardo DRS, a Nasdaq-listed defense technology company, has scheduled its Q3 2026 earnings conference call for October 29, 2026. The company will release its quarterly results prior to the call, which will focus on its performance and outlook in delivering advanced defense solutions for U.S. national security and allied customers.
AgEagle Aerial Systems Inc. (EagleNXT) successfully demonstrated its newly developed anti-jamming technology for drones in the Denied, Disrupted, Intermittent and Limited (DDIL) environment at Michigan's National All-Domain Warfighting Center. The technology showed strong performance in realistic contested conditions, supporting the U.S. Army's Per…
HUHUTECH International Group Inc. expects two key projects in Japan, valued at approximately $12 million, to advance toward contracting in Q4 2026. These projects, involving power system engineering and heated piping system integration, would begin execution in mid-2027 and continue through 2028. The developments underscore the company's continued …
IMUNON, Inc., a clinical-stage biotechnology firm, completed an exchange agreement converting $1.2 million of outstanding debt into Series B Preferred Stock, reducing debt by approximately 43% and increasing shareholders' equity. The transaction was done without issuing common stock or dilutive warrants, preserving financial flexibility and minimiz…
argenx SE announced new clinical, long-term, and real-world evidence data on its lead drug VYVGART for treating myasthenia gravis (MG) and chronic inflammatory demyelinating polyneuropathy (CIDP), along with promising results for pipeline drugs empasiprubart and adimanebart. The data show sustained efficacy, safety, and benefits of earlier treatmen…
